Post-approval studies (Phase 4)Study completedNCT02982850
What this trial is testing
Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease
Who this might be right for
Atrial FibrillationValve Heart Disease
Asan Medical Center 120